Interobserver variations in histopathological assessment of gastric pathology

Pathology

Volumn 41, Issue 5, 2009, Pages 428-432

  Talebkhan, Yeganeh ^a   Mohammadi, Marjan ^a   Rakhshani, Naser ^b   Abdirad, Afshin ^b   Fayaz Moughadam, Katayoun ^c   Fereidooni, Foruzandeh ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Park Clinical Laboratory   (Iran)

Author keywords

Agreement; Gastritis; Grading; Histology

Indexed keywords

ARTICLE; ATROPHY; CHRONIC GASTRITIS; CLINICAL ARTICLE; DYSPLASIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; INTESTINE METAPLASIA; LYMPH FOLLICLE; OBSERVER VARIATION; PATHOLOGIST; REPRODUCIBILITY; SCORING SYSTEM; STOMACH; STOMACH DISEASE;

EID: 70350633008     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903041044     Document Type: Article

References (39)

1. Soll AH. Gastritis and Helicobacter pylori. In: Goldman L, Bennett JC, editors. Cecil Text Book of Medicine. 21st ed. Philadelphia: Saunders, 2000; 643-767.
2. Genta RM. Inflammatory disorders of the stomach. In: Odze RD, Goldblum JR, Crawford DH, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Philadelphia: Saunders, 2004; 143-176
3. Peterson WL, Graham DY. Helicobacter pylori. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Pathophysiology (Diagnosis) Management. 6th ed. Philadelphia: Saunders, 1998; 604-620
4. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7- 14 June1994. IARC Monogr Eval Carcinog Risk Hum 1994; 61: 21-241.
6. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789
7. Maeda S, Yoshida H, Ogura K, et al. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer 2000; 88: 1530-1535
8. Correa P, Cuello C, Duque E, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976; 57: 1027-1035
9. Sipponen P, Kekki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer 1983; 52: 1062-1068
10. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004; 157: 301-310
11. El-Zimaity HM. Gastric atrophy, diagnosing and staging. World J Gastroenterol 2006; 12: 5757-5762
12. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-636
13. Misiewice JJ, Tytgat GNJ, Goodwin CS. The Sydney system: a new classification of gastritis. J Hepathol Gastroenterol 1991; 6: 209-222
14. Genta RM, Dixon MF. The Sydney system revisited: The Houston international gastritis workshop. Am J Gastroenterol 1995; 90: 1039-1041
15. Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis. Pathogenesis and definition of gastric atrophy. Gastroenterology 1997; 113 (Suppl): 551-555
16. El-Zimaity HM, Graham DY, al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 35-41.
17. van Grieken NC, Weiss MM, Meiger GA, et al. Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol 2001; 54: 63-69
18. Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996; 20 (Suppl 1): S23-S30.
19. Genta RM. Review article: gastric atrophy and atrophic gastritis- nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998; 12 (Suppl 1): 17-23.
20. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994; 25: 317-322
21. Chen XY, van der Hulst RWM, Bruno MJ, et al. Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol 1999; 52: 612-615
22. Offerhaus GJ, Price AB, Haot J, et al. Observer agreement on the grading of gastric atrophy. Histopathology 1999; 34: 320-325
23. Genta RM. Pathology of Helicobacter pylori infection. In: Weinstein RS, editor. Advances in Pathology and Laboratory Medicine. St Louis: Mosby, 1994; 443-465
24. Tepes B, Ferlan-Marolt V, Jutersek A, et al. Interobserver agreement in the assessment of gastritis reversibility after Helicobacter pylori eradication. Histopathology 1999; 34: 124-133
25. Dixon MF, Genta RM, Yardly JH, et al. Classification and grading of gastritis, the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-1181
26. El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 2001; 54: 679-683
27. El-Zimaity HM, Ota H, Graham DY, et al. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 2002; 94: 1428-1436
28. Ricuarte O, Gutierrez O, Cardona H, et al. Atrophic gastritis in young children and adolescents. J Clin Pathol 2005; 58: 1189-1193
29. Genta RM, Rugge M. Assessing risks for gastric cancer: New tools for pathologists. World J Gastroenterol 2006; 12: 5622-5627
30. Rugge M, Cassaro M, Di Mario F, et al. The long term outcome of gastric non-invasive neoplasia. Gut 2003; 52: 1111-1116
31. Massarrat S, Saberi-Firoozi M, Soleimani A, et al. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995; 7: 427-433
32. Iranian Disease Prevention and Control Department. Cancer Incidence in Iran. Tehran: Ministry of Health and Medical Education, 2006; 6.
33. Sajadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int J Cancer 2003; 107: 113-118
34. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process. First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-6740
35. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19 (Suppl 1): S37-S43.
36. Rugge M, Cassaro M, Leandro G, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996; 41: 950-955
37. Sipponen P. Gastric cancer a long term consequence of Helicobacter pylori infection? Scand J Gastroenterol Suppl 1994; 201: 24-27
38. Meining A, Stolte M. Close correlation of intestinal metaplasia and corpus gastritis in patients infected with Helicobacter pylori. Z Gastroenterol 2002; 40: 557-560
39. Aydin O, Egilmez R, Karabacak T, et al. Interobserver variation in histopathological assessment of Helicobacter pylori gastritis. World J Gastroenterol 2003; 9: 2232-2235